Market Research Logo

Mexico Pharmaceuticals and Healthcare Report Q4 2015

Mexico Pharmaceuticals and Healthcare Report Q4 2015

BMI View: Robust relations with the US will continue to result in the growth of Mexico's pharmaceuticaland healthcare markets in 2015. Mexico's work to expand its international reach along with its positiveeconomic outlook posture it to act as an outperformer in Latin America. Governmental focus on costcontainmentinitiatives will result in a booming demand for generic medications, as Mexico maintains itsstatus as one of the largest consumers of generic drugs worldwide.

Headline Expenditure Projections

Pharmaceuticals: MXN173bn (USD13bn) in 2014 to MXN177bn (USD12bn) in 2015; +2.7% in localcurrency terms and -9.5% in US dollar terms. Forecast revised downwards from Q315 due to revisedhistorical data.


BMI Industry View
SWOT
Political
Economic
Operational Risk
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Mexico 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Mexico 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Mexico 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Mexico 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Mexico 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Mexico 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Mexico 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Table: GDP By Expenditure (Mexico 2012-2019)
Pharmaceuticals & Healthcare Risk/Reward Index
Americas Risk/Reward Index - Q4 2015
Mexico Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Sector
Table: Healthcare Resources (Mexico 2009-2014)
Table: Healthcare Personnel (Mexico 2009-2014)
Table: Healthcare Activity (Mexico 2009-2014)
Table: List Of Hospitals In Mexico With Joint Commission International (JCI) Accreditation
Research And Development
Clinical Trials
Regulatory Development
Regulatory Developments
Biologics And Biosimilars Guidelines
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Competitive Landscape
Research-Based Industry
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Table: IMSS Financial Indicators, 2000-11 (MXNmn)
Company Profile
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Genomma Labs
GlaxoSmithKline (GSK)
Merck KGaA
Novartis
Pfizer
Roche
Sanofi
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Mexico 1990-2025)
Table: Key Population Ratios (Mexico 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Mexico 1990-2025)
Table: Population By Age Group (Mexico 1990-2025)
Table: Population By Age Group % (Mexico 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report